International Society For Pharmaceutical Engineering Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 115,528 | 118,054 | −2,526 | 9.6 | — |
| 2012 | 172,999 | 164,235 | 8,764 | 7.5 | — |
| 2013 | 140,430 | 143,528 | −3,098 | 8.4 | — |
| 2014 | 108,272 | 112,049 | −3,777 | 10.3 | — |
| 2015 | 117,377 | 114,185 | 3,192 | 10.5 | — |
| 2016 | 172,728 | 142,615 | 30,113 | 10.9 | — |
| 2017 | 169,161 | 133,099 | 36,062 | 14.9 | — |
| 2018 | 154,190 | 152,505 | 1,685 | 13.2 | — |
| 2019 | 203,605 | 173,995 | 29,610 | 13.6 | 0% |
| 2020 | 61,063 | 63,680 | −2,617 | 36.6 | — |
| 2021 | 100,150 | 124,511 | −24,361 | 16.4 | — |
| 2022 | 175,898 | 185,881 | −9,983 | 10.3 | — |
| 2023 | 300,106 | 229,243 | 70,863 | 12.1 | 0% |
In its most recent public year (2023), this organization brought in $70,863 more than it spent. Its reserves stood at about 12.1 months of spending, up from 9.6 in 2011. Staff pay was 0% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
International Society For Pharmaceutical Engineering Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works